EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Kisspeptin Administration Stimulates Reproductive Hormones but Does Not Affect Anxiety in Humans

Edouard G Mills iD, Layla Thurston, Lisa Yang, Tia Hunjan, Maria Phylactou iD, Bijal Patel, Sophie A Clarke, Chioma Izzi-Engbeaya iD, Jovanna Tsoutsouki, Megan Young, Paul Bech, Natalie Ertl und 4 weitere

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgaf128 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Edouard G Mills und 15 weiteren Autor:innen. Beteiligte Einrichtung: Section of Endocrinology and Investigative Medicine, Imperial College London, London W12 0NN, UK. Hauptthemen laut MEDLINE: Kisspeptins, Anxiety. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR, NIHR Imperial Biomedical Research Centre, NIHR Imperial Clinical Research Facility.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Kisspeptin is a critical endogenous activator of the reproductive system, with escalating clinical interest as a novel therapeutic for common reproductive and psychosexual disorders. However, conflicting animal data suggest that kisspeptin can have anxiolytic, neutral, or anxiogenic effects.

Objective

Given the rapid development of kisspeptin-based therapeutics, it is important to comprehensively investigate the effects of kisspeptin administration on behavioral, biochemical, and physiological measures of anxiety in humans.

Methods

Ninety-five participants (N = 63 male, N = 32 female) completed a double-blind, randomized, placebo-controlled, crossover protocol (mean age ± SEM 30.9 ± 0.9 y, body mass index 24.0 ± 0.4), attending both for a 75-minute intravenous kisspeptin-54 infusion (1 nmol/kg/h) and rate-matched placebo (in random order). Behavioral, biochemical, and physiological measures of anxiety were compared between kisspeptin and placebo visits, using a state-anxiety psychometric questionnaire before and at the end of the infusions, and blood sampling (for reproductive hormones and cortisol) and heart rate measurements at 15-minute intervals. Blood pressure assessment took place before and at the end of the infusions.

Results

Kisspeptin administration robustly increased serum luteinizing hormone to similar levels previously described using this administration protocol, confirming that the dose was biologically active (P < .001). State anxiety was not significantly altered by kisspeptin, compared to placebo (P = .13). Moreover, kisspeptin had no significant effects on circulating cortisol (P = .73), systolic (P = .74) or diastolic blood pressure (P = .90), or heart rate (P = .52).

Conclusion

This is the first study demonstrating that a biologically active dose of kisspeptin to men and women does not affect behavioral, biochemical, or physiological measures of anxiety. Given that animal studies have yielded contradictory results, this provides key clinical data and reassurance that kisspeptin does not induce anxiety in humans and so informs the current development of kisspeptin-based therapeutics for common reproductive and psychosexual disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KisspeptinsAnxietyHumansFemaleMaleDouble-Blind MethodAdultCross-Over StudiesYoung AdultLuteinizing HormoneHydrocortisoneHeart Rate

Stichwörter der Autor:innen

anxietybehaviorkisspeptinreproduction

Substanzen

KisspeptinsLuteinizing HormoneKISS1 protein, humanHydrocortisone

Autor:innen und Institutionen

  • Section of Endocrinology and Investigative Medicine, Imperial College London, London W12 0NN, UK.
  • Department of Endocrinology, Imperial College Healthcare NHS Trust, London W6 8RF, UK.
  • Clinical Imaging Services, Perceptive London, London W12 0NN, UK.

ORCID-Profile: Edouard G Mills, Maria Phylactou, Chioma Izzi-Engbeaya, Ali Abbara, Alexander N Comninos, Waljit S Dhillo

Förderung

  • NIHR
  • NIHR Imperial Biomedical Research Centre
  • NIHR Imperial Clinical Research Facility
  • MRC
  • NHS
  • Department of Health
  • NIHR Academic Clinical Lectureships
  • MRC Clinical Research Training Fellowships

Zitieren

APA

Mills, E. G., Thurston, L., Yang, L., Hunjan, T., Phylactou, M., Patel, B., Clarke, S. A., Izzi-Engbeaya, C., Tsoutsouki, J., Young, M., Bech, P., Ertl, N., Wall, M. B., Abbara, A., Comninos, A. N., & Dhillo, W. S. (2025). Kisspeptin Administration Stimulates Reproductive Hormones but Does Not Affect Anxiety in Humans. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf128

Vancouver

Mills EG, Thurston L, Yang L, Hunjan T, Phylactou M, Patel B, et al. Kisspeptin Administration Stimulates Reproductive Hormones but Does Not Affect Anxiety in Humans. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf128

BibTeX
@article{Mills2025,
  author = {Mills, Edouard G and Thurston, Layla and Yang, Lisa and Hunjan, Tia and Phylactou, Maria and Patel, Bijal and Clarke, Sophie A and Izzi-Engbeaya, Chioma and Tsoutsouki, Jovanna and Young, Megan and Bech, Paul and Ertl, Natalie and Wall, Matthew B and Abbara, Ali and Comninos, Alexander N and Dhillo, Waljit S},
  title = {Kisspeptin Administration Stimulates Reproductive Hormones but Does Not Affect Anxiety in Humans},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgaf128}
}
Kostenlos starten →